Cyclic adenosine monophosphate protects renal cell lines against amphotericin B toxicity in a PKA-independent manner

A F Ferreira1, F D França1, J V Rossoni2

  • 1a Departamento de Bioquímica e Imunologia , Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais , Belo Horizonte , MG , Brazil .

Insights

Cyclic adenosine monophosphate (cAMP) protects kidney cells from Amphotericin B-induced toxicity. This study found that cAMP prevents renal cell death independently of protein kinase A (PKA), offering a novel protective strategy.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Amphotericin B (AmB) is crucial for treating systemic fungal infections but causes significant nephrotoxicity.
  • This drug-induced kidney injury contributes to a substantial portion of acute kidney injuries in critical care settings.
  • Cyclic adenosine monophosphate (cAMP) has demonstrated protective effects on kidney cells against various injuries.

Purpose of the Study:

  • To investigate the potential of cAMP in preventing Amphotericin B-induced cell death in renal cell lines.
  • To determine the involvement of protein kinase A (PKA) in the protective signaling pathway of cAMP against AmB toxicity.

Main Methods:

  • Utilized two distinct renal cell lines: LLC-PK1 and MDCK.
  • Employed MTT and flow cytometry assays to assess cell viability and survival rates.
  • Confirmed signaling pathways using western blot analysis.

Main Results:

  • Exposure to cAMP significantly increased cell survival in renal cell lines treated with Amphotericin B.
  • The protective effect of cAMP was observed to be independent of protein kinase A (PKA) activation.
  • Western blot analysis corroborated the PKA-independent nature of the observed protection.

Conclusions:

  • Cyclic adenosine monophosphate (db-cAMP) demonstrates a protective effect against Amphotericin B-induced nephrotoxicity in renal cell lines.
  • This protective mechanism operates independently of the protein kinase A (PKA) signaling pathway.
  • This represents a novel finding in understanding the potential therapeutic strategies against AmB-related kidney injury.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
100
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
81
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
394
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
7.0K